Potential therapeutic benefits of cannabinoid products in adult psychiatric disorders: A systematic review and meta-analysis of randomised controlled trials.

导出 LinkOut

翻译打印收藏纠错

作者： Kyle A,McKee ^[1] ; Amira,Hmidan ^[1] ; Candice E,Crocker ^[2] ; Raymond W,Lam ^[3] ; Jeffrey H,Meyer ^[4] ; David,Crockford ^[5] ; Annie,Trépanier ^[6] ; Katherine J,Aitchison ^[7] ; Philip G,Tibbo ^[8]

作者单位： Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada. ^[1] Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Diagnostic Imaging, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada. ^[2] Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada. ^[3] Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. ^[4] Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada. ^[5] Department of Psychiatry, Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montréal, Québec, Canada. ^[6] Department of Psychiatry and Medical Genetics, Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada; Department of Psychiatry, Northern Ontario School of Medicine, Laurentian University, Sudbury, Ontario, Canada. ^[7] Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada. Electronic address: phil.tibbo@nshealth.ca. ^[8]

关键词 Cannabinoid Cannabis Mental disorder Meta-analysis Systematic review Therapeutic